120 related articles for article (PubMed ID: 14631806)
21. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
Irshaid L; Xu ML
Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671
[TBL] [Abstract][Full Text] [Related]
22. Quantitative PCR detection of NPM/ALK fusion gene and CD30 gene expression in patients with anaplastic large cell lymphoma--residual disease monitoring and a correlation with the disease status.
Kalinova M; Krskova L; Brizova H; Kabickova E; Kepak T; Kodet R
Leuk Res; 2008 Jan; 32(1):25-32. PubMed ID: 17320171
[TBL] [Abstract][Full Text] [Related]
23. Timely topic: anaplastic lymphoma kinase (ALK) spreads its influence.
Cheuk W; Chan JK
Pathology; 2001 Feb; 33(1):7-12. PubMed ID: 11280613
[TBL] [Abstract][Full Text] [Related]
24. Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity.
Hernández L; Beà S; Bellosillo B; Pinyol M; Falini B; Carbone A; Ott G; Rosenwald A; Fernández A; Pulford K; Mason D; Morris SW; Santos E; Campo E
Am J Pathol; 2002 Apr; 160(4):1487-94. PubMed ID: 11943732
[TBL] [Abstract][Full Text] [Related]
25. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
26. Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood.
Hutchison RE; Banki K; Shuster JJ; Barrett D; Dieck C; Berard CW; Murphy SB; Link MP; Pick TE; Laver J; Schwenn M; Mathew P; Morris SW
Ann Oncol; 1997; 8 Suppl 1():37-42. PubMed ID: 9187427
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.
Krenacs L; Wellmann A; Sorbara L; Himmelmann AW; Bagdi E; Jaffe ES; Raffeld M
Blood; 1997 Feb; 89(3):980-9. PubMed ID: 9028330
[TBL] [Abstract][Full Text] [Related]
28. NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma.
Quintanilla-Martinez L; Pittaluga S; Miething C; Klier M; Rudelius M; Davies-Hill T; Anastasov N; Martinez A; Vivero A; Duyster J; Jaffe ES; Fend F; Raffeld M
Blood; 2006 Sep; 108(6):2029-36. PubMed ID: 16709933
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
Rassidakis GZ; Sarris AH; Herling M; Ford RJ; Cabanillas F; McDonnell TJ; Medeiros LJ
Am J Pathol; 2001 Aug; 159(2):527-35. PubMed ID: 11485911
[TBL] [Abstract][Full Text] [Related]
30. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
[TBL] [Abstract][Full Text] [Related]
31. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Lai R; Rassidakis GZ; Medeiros LJ; Ramdas L; Goy AH; Cutler C; Fujio Y; Kunisada K; Amin HM; Gilles F
Am J Pathol; 2004 Jun; 164(6):2251-8. PubMed ID: 15161657
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma.
Li C; Takino H; Eimoto T; Ishida T; Inagaki A; Ueda R; Suzuki R; Yoshino T; Nakagawa A; Nakamura S; Inagaki H
Mod Pathol; 2007 Jun; 20(6):648-55. PubMed ID: 17464320
[TBL] [Abstract][Full Text] [Related]
33. Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: a genetic and pathological correlation.
Perkins SL; Pickering D; Lowe EJ; Zwick D; Abromowitch M; Davenport G; Cairo MS; Sanger WG
Br J Haematol; 2005 Dec; 131(5):624-7. PubMed ID: 16351638
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro.
Hsu FY; Zhao Y; Anderson WF; Johnston PB
Cancer Invest; 2007 Jun; 25(4):240-8. PubMed ID: 17612934
[TBL] [Abstract][Full Text] [Related]
35. Is ALK-gene rearrangement overlooked in primary gastrointestinal T-cell lymphomas? About two cases.
Mneimneh WS; Vyas SG; Cheng L; Cummings OW; Czader M
Pathol Int; 2015 Dec; 65(12):666-70. PubMed ID: 26531107
[TBL] [Abstract][Full Text] [Related]
36. [Diffuse large B-cell lymphoma with expression of anaplastic lymphoma kinase protein: clinicopathologic and immunohistochemical study of 5 cases].
Wang WY; Ma ZG; Li GD; Liu WP; Zhong L; Wang Y; Li JM; Li L; Jiang W; Tang Y; Liao DY
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):529-34. PubMed ID: 17134546
[TBL] [Abstract][Full Text] [Related]
37. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
King RL; Dao LN; McPhail ED; Jaffe ES; Said J; Swerdlow SH; Sattler CA; Ketterling RP; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Gibson SE; Ondrejka SL; Nicolae A; Macon WR; Dasari S; Parrilla Castellar E; Feldman AL
Am J Surg Pathol; 2016 Jan; 40(1):36-43. PubMed ID: 26379151
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
Rassidakis GZ; Goy A; Medeiros LJ; Jiang Y; Thomaides A; Remache Y; Cabanillas F; Sarris AH; Gilles F
Clin Cancer Res; 2003 Jun; 9(6):2213-20. PubMed ID: 12796388
[TBL] [Abstract][Full Text] [Related]
39. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Palestro G; Inghirami G; Chiarle R
Cancer Res; 2007 May; 67(9):4278-86. PubMed ID: 17483340
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
Eckerle S; Brune V; Döring C; Tiacci E; Bohle V; Sundström C; Kodet R; Paulli M; Falini B; Klapper W; Chaubert AB; Willenbrock K; Metzler D; Bräuninger A; Küppers R; Hansmann ML
Leukemia; 2009 Nov; 23(11):2129-38. PubMed ID: 19657361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
